Seeking Alpha

Globus Medical beats, raises EPS guidance

  • Globus Medical's (GMED) Q3 numbers come in slightly ahead of the Street's expectations.
  • U.S. sales growth for the period was 12.6%, while international growth was 19.1%.
  • Net income rises 23% Y/Y to $20.3M.
  • FY13 outlook: $0.83-0.85/share (versus previous guidance of $0.81/share) on revenue of ~$432M. Consensus is $0.83/share on sales of $432.3M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: